Skip to Content

LL 35 (EndaCof Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg)

Generic Name: guaifenesin/hydrocodone

Pill with imprint LL 35 is White, Capsule-shape and has been identified as EndaCof Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg. It is supplied by Larken Laboratories, Inc..

EndaCof-Tab is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. EndaCof-Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for LL 35

EndaCof Tab

Generic Name
guaifenesin/hydrocodone
Imprint
LL 35
Strength
guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Larken Laboratories, Inc.
National Drug Code (NDC)
54868-5492

Get help with Imprint Code FAQs.

Related Images for "LL 35"

More about EndaCof-Tab (guaifenesin / hydrocodone)

Consumer resources

Other brands
Narcof, Canges-XP, CodiCLEAR DH, Execlear, ... +5 more

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.